STOCK TITAN

eGain Corporation Form 4 Filings

EGAN NASDAQ

Every Form 4 that eGain Corporation (EGAN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow EGAN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EGAN filings page.

Rhea-AI Summary

EGAIN Corp SVP, Products and Services Rao Jadcherla Chandrasekhar exercised options for 6,000 shares at $2.50 per share on October 1, 2026, and sold 6,000 common shares that day at a weighted average price of $5.8769 per share. The sale was made under a Rule 10b5-1 trading plan adopted June 9, 2026. After the exercise, the option position was 49,003 shares and expires September 19, 2027.

Rhea-AI Summary

EGAIN Corp (EGAN) reported that Senior Vice President, Products and Services, Chandrasekhar Rao Jadcherla exercised employee stock options for 6,000 shares at an exercise price of $2.50 per share on September 15, 2026, receiving the same number of common shares and then selling 6,000 shares at about $5.15 per share in multiple trades, all under a Rule 10b5-1 trading plan adopted on June 9, 2026. After the option exercise, 55,003 option shares remain outstanding from the original grant of 61,003 shares, which has been fully vested since it first became exercisable on September 19, 2017.

Rhea-AI Summary

eGain Corp Chief Financial Officer Eric Smit reported an exercise and sale of company stock. On February 2, 2026, he exercised 5,000 employee stock options at an exercise price of $2.50 per share and received an equal number of common shares.

On the same day, he sold 5,000 shares of common stock at $10.25 per share under a Rule 10b5-1 trading plan adopted on March 8, 2024. After these transactions, he directly held 129,187 shares of common stock and 23,000 employee stock options that remain outstanding.

Rhea-AI Summary

eGain (EGAN) insider activity: the Chief Financial Officer reported Form 4 transactions on 11/03/2025. He exercised 5,000 stock options at $2.5 and sold 5,000 common shares at an average price of $14.44 pursuant to a Rule 10b5-1 plan adopted on March 8, 2024.

After these trades, he directly holds 129,187 common shares and 38,000 stock options remain beneficially owned. The reported sales were executed across multiple trades between $14.23 and $14.74.

Rhea-AI Summary

eGain (EGAN) reported an insider transaction by director Phiroz P. Darukhanavala. On 10/28/2025, he exercised stock options (transaction code M) for 500 shares of common stock at $4.335 per share. Following the transaction, he beneficially owns 3,000 shares directly.

The exercised option covered 500 underlying shares and now shows 0 derivative securities remaining. The option was fully vested on 11/06/2016 and carried an expiration date of 11/06/2025.

Rhea-AI Summary

eGain (EGAN) director reported an option exercise. On 10/24/2025, the reporting person exercised stock options and acquired 500 shares of Common Stock at $4.335 per share (Transaction Code M). Following the transaction, direct beneficial ownership stood at 819,795 shares. The exercised options represented the right to buy 500 shares and, after the transaction, 0 derivative securities remained. The options became fully vested on November 6, 2016.